Visual estimation of blood loss

misses half of postpartum haemorrhages.

Within minutes of each vaginal birth, a decision is made on whether to begin treatment based on the amount of blood loss. This decision is still based on visually estimated or ‘guesstimated’ blood loss. Diagnostic tools now provide evidence showing how often these visual assessments are incorrect.

The problem with visual estimation

Postpartum haemorrhage is often estimated visually by looking at blood loss on pads, bed linen, and the floor.

Visual estimation of blood loss after vaginal birth fails to identify at least 52 out of 100 true cases of postpartum haemorrhage. Conversely, using a calibrated blood-collection drape combined with abnormal vitals reduces missed cases of postpartum haemorrhage to just 7 out of 100 (sensitivity of 93%) [1].

291,040

Women pooled across 18 studies — the largest diagnostic review of PPH detection [1]

The limits of visual estimation

01 –Guesstimation

The blood spreads

After a vaginal birth, blood isn’t concentrated in a single area, making it hard to determine the actual amount.

An animation: blood pooling in a calibrated drape stays concentrated and easy to read, while the same volume spread thin across pads and floor tiles looks like far less. This dispersal is why the eye underestimates blood loss.

Visual estimation – underestimates blood loss

02 – Inaccuracy

The eye underestimates

Visual estimates tend to underestimate, and inaccuracy increases with greater volume loss: visual estimation detected fewer than 1 in 10 severe haemorrhages [1].

03 – Objectively measuring blood loss is now recommended

Objective blood loss measurement using a calibrated drape improves early PPH diagnosis. It ensures excessive bleeding is recognised promptly, so that women get timely treatment without avoidable delays.

The problem

SUGGESTED · Section title: The problem with the 500 mL threshold

The 500 mL threshold has been the standard for decades, established by convention rather than by scientific evidence [3]. This threshold was applied to all women and has been the standard for decades; however, different women tolerate blood loss differently. A woman with severe anaemia may be compromised even at 300 mL, while women with healthy physiological reserves may tolerate more. A threshold based on volume alone can therefore identify PPH too late [3] [4].

The calibrated blood loss collection drape

01 – Placement

Applied right after birth

A simple, low-cost calibrated drape, applied once amniotic fluid has drained and before placental delivery.

Close-up of a calibrated blood-collection drape, its calibrations printed in millilitres running from 100 to 1500, with collected blood visible at the 500 millilitre mark.

Calibrated drape - the whole team can easily read

02 – Calibrated drape

Blood loss is easily read by the whole team

The drape collects the postpartum blood loss, giving an accurate, measurable blood-loss figure that the entire team can easily read [3] [5].

03 – Monitoring

In place for at least an hour

Hanging from the edge of the bed; longer if bleeding continues; and monitored alongside uterine tone, ongoing bleeding, pulse, and blood pressure at least every 15 minutes [3] [5].

In practice · Two illustrative scenarios

Based on E-MOTIVE trial observations

A midwife uses a calibrated drape after every birth.

Two births, two sets of readings, and the same question each time. Is this postpartum haemorrhage? Objective measurement identifies PPH that estimation misses.

Scenario

Estimated

Objectively measured

The call

Scenario 1

≈200 mL

580 mL

PPH

≥500 mL

Treatment triggered by objective measurment

Scenario 2

≈150 mL

400 mL

NOT PPH

≥500 mL

Treatment not triggered

Objective measurement answers the first question after birth: how much blood has been lost.

The next question is: at what threshold is treatment triggered?

The updated definition of PPH: an action threshold.

For many years, the key question after birth was “has she lost 500 mL yet?” The consolidated WHO–FIGO–ICM guideline for PPH now shifts that focus to a different question: based on her current physiological status, "Is her current blood loss enough to warrant immediate action?" [5]?

The evidence behind it

A WHO IPD analysis evaluated objectively measured blood loss and vital signs, individually and in combination, as predictors of maternal death and severe morbidity [2].

Using a combined criterion of a lower blood-loss threshold (<500 mL; 300–450 mL) with at least one abnormal vital sign, predicted PPH with a sensitivity of 87–88% (the trigger identifies 87–88 out of every 100 women at risk of death or life-threatening complications) and a specificity of 67–76% (for every 100 women who would have recovered without treatment, the trigger treats 24–33 as a precaution).

In practice · Three illustrative scenarios

Based on E-MOTIVE trial observations and the WHO–FIGO–ICM trigger criteria.

A midwife uses a calibrated drape after every birth. Three births, three sets of readings — and the same question each time: is this postpartum haemorrhage?

Scenario

Objectively measured

Her pulse

The call

Scenario 1

580 mL

78 bpm

NORMAL

PPH

≥500 mL

Treatment triggered by volume alone.

Scenario 2

350 mL

118 bpm

ABNORMAL

PPH

≥300 mL + one abnormal vital sign

Treatment triggered [4]

Scenario 3

400 mL

84 bpm

NORMAL

NO PPH

Below 500 mL, vitals normal

Treatment not triggered. Observe.

What changes when you measure objectively

Recorded postpartum haemorrhage rates increase as facilities move from visual estimation to objective measurement of blood loss. This allows previously undetected cases to now be identified, and the rise should be interpreted as better detection. It is important to clearly communicate this to hospital boards, ministries, and media before the first post-implementation audit [3].

The key outcome is not just the recorded rate but the decrease in missed cases of severe postpartum haemorrhage, blood transfusions, laparotomies, hysterectomies, and death due to bleeding.

Conceptual bar chart: recorded PPH cases rise when blood loss is measured objectively rather than estimated visually, because previously undetected cases are now identified. The rise means better detection, not deteriorating care.

What it means for healthcare systems

The first response treatment (MOTIVE) is triggered by objectively measured blood loss of 300 mL or more with one abnormal clinical sign or blood loss of greater than 500mL. The WHO now recommends this trigger [4] [6].

In practice, applying this definition involves two key steps:

  • objectively measuring blood loss at each birth with a calibrated drape
  • ensuring healthcare workers are trained to initiate treatment once the trigger condition is met.